Page last updated: 2024-12-05

4-methylmorpholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-Methylmorpholine (4-MM) is a heterocyclic amine compound used as a solvent and a catalyst in various organic reactions. It is a colorless liquid with a characteristic amine-like odor and is miscible with water. Its synthesis typically involves the reaction of morpholine with formaldehyde and formic acid. 4-MM has been studied for its potential applications in various fields, including pharmaceuticals, polymers, and agrochemicals. Its high basicity makes it a suitable base in organic synthesis. Its catalytic properties have also been explored in reactions such as esterification, amidation, and transesterification. Notably, 4-MM is used in the synthesis of several pharmaceutical compounds and is also a component of various pesticides. Research into 4-MM continues to explore its potential in diverse applications, including its role in green chemistry approaches and its ability to improve the efficiency of various chemical reactions.'

Cross-References

ID SourceID
PubMed CID7972
CHEMBL ID2448839
SCHEMBL ID4622
MeSH IDM0116646

Synonyms (97)

Synonym
4-methylmorpholin
STL294217
ai3-24289
einecs 203-640-0
ccris 6691
4-methylmorfolin [czech]
nsc 9382
un2535
methylmorpholine
109-02-4
4-methylmorpholine ,
n-methylmorpholine
morpholine, n-methyl-
wln: t6n dotj a1
nsc-9382
1-methylmorpholine
nsc9382
morpholine, 4-methyl-
n-methyl morpholine hydrochloride
inchi=1/c5h11no/c1-6-2-4-7-5-3-6/h2-5h2,1h
NMM ,
4-methylmorpholine, purified by redistillation, >=99.5%
4-methylmorpholine, reagentplus(r), 99%
4-methylmorpholine, bioxtra, suitable for protein sequencing, >=99.5% (gc)
4-methylmorfolin
morpholine, 4-methyl
AKOS000118797
FT-0658371
M0370
NCGC00249222-01
4-methyl-morpholine
n-methyl morpholine
n-methylmorpholin
4-methylmorpholine or n-methylmorpholine
11p91anu5x ,
4-methylmorpholine or n-methylmorpholine [un2535] [flammable liquid]
ec 203-640-0
unii-11p91anu5x
dtxcid709146
NCGC00257448-01
dtxsid9029146 ,
cas-109-02-4
tox21_303402
tox21_202412
NCGC00259961-01
CHEMBL2448839
BP-20398
FT-0648820
n-methylmorpholine [mi]
SCHEMBL4622
n- methyl morpholine
4-methyl morpholine
n-methyl morpholin
n-methylmorphline
4-(methyl)morpholine
4-methylmopholine
n-methyhnorpholine
4-methymorpholine
4 -methylmorpholine
n-methyl-mopholine
n -methylmorpholine
n-methyimorpholine
4-n-methylmorpholine
4-methyimorpholine
n-metyl-morpholine
n-methyl -morpholine
n--methylmorpholine
n-methylmorpho-line
4-methyl morpholin
4-methlmorpholine
n-methylmopholine
4methylmorpholine
n-methymorpholine
n-methylmor-pholine
n- methylmorpholine
n-metylmorpholine
n-mehtyl morpholine
n-methyl-morpholin
methyl-morpholine
4-methyl-1-oxa-4-azacyclohexane
p-methyl morpholine
un 2535
texacat nmm
STR02354
mfcd00006175
J-002223
J-515790
4-methylmorpholine, purum, >=98.0% (gc)
F0001-0190
n-methylmorpholine, saj special grade, >=99.0%
4-methylmorpholine, redistilled
FT-0701320
Q2542075
n-methyl morphofine pound>>morpholine, 4-methyl-
BCP31356
EN300-18961
Z103717380

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" However, no adverse effects on reproductive organs have been reported in studies conducted with NMMO, and the mode of action (MOA) for the effects of NMMO on spermatogenesis is unknown, which complicates the interpretation of these data for human risk assessment."( An in vitro approach to determine the human relevance of anti-spermatogenic effects of 4-methylmorpholine 4-oxide, monohydrate (NMMO) in rat reproductive toxicity studies.
Clewell, HJ; Clewell, RA; Easley, CA; Gentry, R; Langmo, JN; Linakis, MW; Rücker, T; Salley, J, 2022
)
0.94

Dosage Studied

ExcerptRelevanceReference
" Dose-response data were collected in isolated germ cells and in an ex vivo seminiferous tubule model that recapitulates the interaction between the somatic environment and differentiating germ cells to account for potential direct and indirect effects on germ cells."( An in vitro approach to determine the human relevance of anti-spermatogenic effects of 4-methylmorpholine 4-oxide, monohydrate (NMMO) in rat reproductive toxicity studies.
Clewell, HJ; Clewell, RA; Easley, CA; Gentry, R; Langmo, JN; Linakis, MW; Rücker, T; Salley, J, 2022
)
0.94
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
farnesoid X nuclear receptorHomo sapiens (human)Potency42.72970.375827.485161.6524AID743220
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.21420.000229.305416,493.5996AID743075
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency43.64120.023723.228263.5986AID743223
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID781327pKa (acid-base dissociation constant) as determined by Morgenthaler ref: ChemMedChem 20072014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID1134914Dissociation constant, pKa of the compound1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (16.00)18.7374
1990's3 (12.00)18.2507
2000's1 (4.00)29.6817
2010's14 (56.00)24.3611
2020's3 (12.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.98 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index5.95 (4.65)
Search Engine Demand Index90.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]